Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2017 Financial Results
Mar 21, 2018 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., March 21, 2018 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases...
Mar 21, 2018 10:58 am UTC| Business
Dublin, March 21, 2018 -- The "Global Undersea Warfare Systems Market: Focus on Weapons and Countermeasures, Sensors and Sonars, Unmanned Underwater systems, Communication Systems and Airborne Detection systems -...
Mar 21, 2018 10:54 am UTC| Business
STEINHAUSEN, Switzerland, March 21, 2018 -- Transocean Ltd. (NYSE:RIG) announced today that the subscription period for Transocean Ltd.’s and Transocean Inc.’s (‟Transocean”) compulsory acquisition of the remaining...
Mar 21, 2018 10:30 am UTC| Business
NEW YORK, March 21, 2018 -- According to a new research report titled “Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics Pipeline Analysis 2018” published by PS Market Research, MRSA therapeutics currently...
Fennec Pharmaceuticals Receives Fast Track Designation by FDA for PEDMARK
Mar 21, 2018 10:30 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., March 21, 2018 -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted...
Global NGS In Agrigenomics Market, 2021 - Market is Expected to Reach $1.38 Billion
Mar 21, 2018 10:26 am UTC| Business
Dublin, March 21, 2018 -- The "Global NGS In Agrigenomics Market - Analysis Forecast, 2017-2021 Focus on Application (Crops and Livestock), Product Type (Kits and Consumables, Instruments and Others) and Region" ...
Cardiovascular Drugs 2018 - Global Markets to 2022
Mar 21, 2018 10:09 am UTC| Business
Dublin, March 21, 2018 -- The "Cardiovascular Drugs: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering. The Report Includes an Industrywide Assessment of the Novel...